Drugs / T20
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00013884 | Mar 2001 → Apr 2003 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T20 | “Fusion Inhibitor T20” NCT00013884 ↗ |
| Action | Inhibit | “T-20, an inhibitor of HIV fusion to T-cells” NCT00013884 ↗ |
| Route | Subcutaneous | “injected under the skin” NCT00013884 ↗ |